Background: Evidence for an inherited genetic risk for pediatric acute lymphoblastic leukemia has been provided in several studies. Most of them focused on coding regions. However, those regions represent only 1.5% of the entire genome. In acute lymphoblastic leukemia (ALL), it has been suggested that the expression of microRNAs (miRNAs) is dysregulated, which suggests that they may have a role in ALL risk. Changes in miRNA function may occur through single-nucleotide polymorphisms (SNPs). Therefore, the aim of this study was to evaluate whether polymorphisms in premiRNAs, and/or miRNA-processing genes, contribute to a predisposition for childhood ALL. Methods: In this study, we analyzed 118 SNPs in pre-miRNAs and miRNA-processing genes in 213 B-cell ALL patients and 387 controls. results: We found 11 SNPs significantly associated with ALL susceptibility. These included three SNPs present in miRNA genes (miR-612, miR-499, and miR-449b) and eight SNPs present in six miRNA biogenesis pathway genes (TNRC6B, DROSHA, DGCR8, EIF2C1, CNOT1, and CNOT6). Among the 118 SNPs analyzed, rs12803915 in mir-612 and rs3746444 in mir-499 exhibited a more significant association, with a P value <0.01. conclusion: The results of this study indicate that SNP rs12803915 located in pre-mir-612, and SNP rs3746444 located in pre-mir-499, may represent novel markers of B-cell ALL susceptibility. a cute lymphoblastic leukemia (ALL) is the most common pediatric hematological malignancy in developed countries. Its etiology is believed to be multifactorial, with both environmental and genetic risk factors being relevant (1). Recently, several studies have provided evidence for an inherited genetic risk for pediatric ALL (2,3). Most of these studies focused on the coding regions of these genetic components. However, this represents only ~1.5% of the entire genome, and noncoding regions of the genome have also been shown to mediate regulatory functions. For example, microRNAs (miRNAs) are a class of small noncoding RNA molecules that regulate gene expression at the posttranscriptional level by binding to the 3′ untranslated region of a target gene (4). This can lead to an inhibition of translation or enhanced degradation of a target mRNA (Figure 1) . Primary double-stranded miRNA transcripts (pri-miRNA) are processed in the nucleus by microprocessor machinery, which includes DROSHA RNase and the double-stranded RNA-binding protein, DGCR8. A hairpin precursor miRNA molecule of 70-100 nucleotides (pre-miRNA) is then produced, and its translocation into the cytoplasm is facilitated by RAN GTPase and Exportin 5 (XPO5). In the cytoplasm, pre-miRNAs are further processed by a protein complex that includes DICER1, TRBP, EIF2C1, EIF2C2, GEMIN3, and GEMIN4, resulting in the production of mature miRNAs (4). It has been predicted that there are more than 1,000 miRNA genes in the human genome (5), and ~30% of human genes are regulated by miRNAs.
a cute lymphoblastic leukemia (ALL) is the most common pediatric hematological malignancy in developed countries. Its etiology is believed to be multifactorial, with both environmental and genetic risk factors being relevant (1) . Recently, several studies have provided evidence for an inherited genetic risk for pediatric ALL (2, 3) . Most of these studies focused on the coding regions of these genetic components. However, this represents only ~1.5% of the entire genome, and noncoding regions of the genome have also been shown to mediate regulatory functions. For example, microRNAs (miRNAs) are a class of small noncoding RNA molecules that regulate gene expression at the posttranscriptional level by binding to the 3′ untranslated region of a target gene (4) . This can lead to an inhibition of translation or enhanced degradation of a target mRNA (Figure 1) . Primary double-stranded miRNA transcripts (pri-miRNA) are processed in the nucleus by microprocessor machinery, which includes DROSHA RNase and the double-stranded RNA-binding protein, DGCR8. A hairpin precursor miRNA molecule of 70-100 nucleotides (pre-miRNA) is then produced, and its translocation into the cytoplasm is facilitated by RAN GTPase and Exportin 5 (XPO5). In the cytoplasm, pre-miRNAs are further processed by a protein complex that includes DICER1, TRBP, EIF2C1, EIF2C2, GEMIN3, and GEMIN4, resulting in the production of mature miRNAs (4) . It has been predicted that there are more than 1,000 miRNA genes in the human genome (5) , and ~30% of human genes are regulated by miRNAs.
In the past few years, it was suggested that miRNAs in ALL are dysregulated. For example, in the study of Zhang et al., up to 171 miRNAs have been found to be differentially expressed between ALL patients and normal donors. These results suggest that dysregulation of these miRNAs may be associated with an increased risk for ALL. Changes in miRNAs function have the potential to affect the expression of a large number of genes, including genes involved in the origin and evolution of pediatric ALL (6, 7) . Changes in miRNA function may occur through genetic variations (4) . For example, single-nucleotide polymorphisms (SNPs) present in genes involved in miRNA processing can affect levels of miRNA expression, whereas SNPs in miRNA genes can affect miRNA biogenesis and function. There have been several polymorphisms found to be associated with other malignancies, and a recent pilot study has found an association between rs2910164 in mir-146a and ALL risk (8) .
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However, despite accumulating evidence that inherited genetic variation can contribute to a predisposition for pediatric ALL and the suggested role of miRNAs in the development of this disease, as well as the role of miRNA-related polymorphisms in cancer risk, the SNPs in miRNA genes and miRNA-processing genes have not been extensively studied in association with pediatric ALL risk.
Therefore, the aim of this study was to evaluate whether polymorphisms in pre-miRNAs, and/or miRNA-processing genes, contribute to a predisposition for childhood ALL.
RESULTS

Genotyping Results
A total of 213 patients with B-cell ALL (B-ALL) and 387 unrelated healthy controls were available for genotyping. Successful genotyping was achieved for 550 DNA samples (91.67%). Of the SNPs, 106/118 (89.83%) were genotyped satisfactorily. Failed genotyping was due to an absence of PCR amplification, insufficient intensity for cluster separation, poor cluster definition, or an inability to define clusters. The average genotyping rate for all SNPs was 98.12%. Furthermore, of the 106 SNPs genotyped, 14 were not in Hardy-Weinberg equilibrium in the population of 387 healthy controls, and therefore, were not considered for further analysis. In total, 26 SNPs were excluded from the association study (see Supplementary  Table S1 online), leaving 92 SNPs available for association studies.
Analysis of Association
To investigate if genetic variation influences the risk of ALL, the 92 polymorphisms successfully genotyped were compared between cases and controls. As shown in Tables 1 and 2, statistically significant associations (P < 0.05) were observed for 11 polymorphisms present in miRNA-related genes. Of these, three were located in pre-miRNAs (Table 1) , and eight were located in miRNA-processing genes ( Table 2) .
Among the SNPs located in pre-miRNA genes, the SNP that was the most significantly associated with ALL risk was 
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Articles SNP rs12803915 in premature mir-612 (Figure 2a) . The A allele for this SNP was found to be protective (odds ratio: 0.61; 95% confidence interval: 0.42-0.88; P = 0.007) in the log-additive (GG vs. GA vs. AA) genetic model. The second most significant association involved SNP rs3746444 in mir-499 (Figure 2b) . Moreover, this SNP is located in the seed region of mature miR-499-3p. The G allele of this SNP was found to be protective (odds ratio: 0.67; 95% confidence interval: 0.49-0.91; P = 0.009) in the log-additive (AA vs. AG vs. GG) genetic model. An association with rs10061133 in mir-449b was also identified ( Table 1) .
These two top SNPs, rs12803915 and rs3746444, were also studied in association with B-hyperdiploid ALL subtype (see Supplementary Tables S2 and S3 online) and chromosomal translocations (data not shown), and no significant differences were found.
In the genes of the miRNA-processing components, the most significant SNP was rs139919, a SNP located in the TNRC6B gene. In the recessive genetic model, the variant homozygous genotype, CC, of this SNP was associated with a 5.1-fold increase in ALL risk (95% confidence interval: 1.31-19.11; P = 0.011). Associations involving rs9606248 and Articles Gutierrez-Camino et al.
in DROSHA, and rs636832 and rs595961 in EIF2C1 were also identified ( Table 2 ). All the SNPs remained significantly associated with ALL risk after multivariate logistic regression to account for the possible confounding effect of sex. These SNPs did not reach the significant value when Bonferroni correction was applied.
DISCUSSION
In this study, 11 SNPs were found to be significantly associated with ALL susceptibility. These included three SNPs present in miRNA genes (miR-612, miR-499, and miR-449b) and eight SNPs present in six miRNA biogenesis pathway genes (TNRC6B, DROSHA, DGCR8, EIF2C1, CNOT1, and CNOT6). Among them, rs12803915 in mir-612 and rs3746444 in mir-499 exhibited a more significant association, with a P value <0.01. In spite of not reaching a significant P value after the restrictive Bonferroni correction, our results point to a putative role of these SNPs in ALL susceptibility, which could be of lower penetrance. SNP rs12803915 located in the premature region of mir-612 showed the strongest association with ALL risk, with the A allele being protective (P = 0.007). To our knowledge, this is the first report of this SNP being associated with cancer risk. It has been suggested that a SNP in the premature region of a miRNA could alter its secondary structure and inhibit or enhance pri-miRNA processing (9) . Therefore, SNPs in miRNAs could lead to dysregulation of miRNA expression (4). Accordingly, it has been shown that SNP rs12803915 significantly decreases mature miR-612 levels, and this may represent a mechanism by which cancer risk is increased (10) . One of the potential targets of mir-612 is IKZF2 (11), a member of the Ikaros family of zinc-finger proteins. This protein is a hematopoietic-specific transcription factor involved in the regulation of lymphocyte development, and other members of this family have been associated with ALL susceptibility (2,3) . Therefore, the presence of SNP rs12803915 in pre-mir-612 may contribute to an increased susceptibility to ALL based on its capacity to affect the expression of mir-612, as well as its downstream targets, such as IKZF2.
The second most significant association identified in this study involved SNP rs3746444 (P = 0.009) located in premir-499. In this case, the G allele was associated with a lower risk for ALL. This SNP has recently been implicated in the etiology of several types of cancer with controversial results. The results of this study are consistent with those of three previous studies, in which the rs3746444 GG genotype was shown to be associated with a decreased risk of cancer (12) (13) (14) . By contrast, in six other studies (5, (15) (16) (17) (18) (19) , the GG genotype was found to be associated with a higher risk of cancer development. There have also been studies that have found no association between this SNP and cancer risk (8, (20) (21) (22) (23) (24) . The inconsistency of these results may be due to differences in the carcinogenic mechanisms of different cancers, as well as differences in genetic backgrounds (25) . Correspondingly, a meta-analysis observed that a tendency for reduced cancer risk was associated with the mir-499 rs3746444 GG genotype in Caucasian populations (26) .
This SNP, rs3746444, is located in pre-mir-499, in the premature sequences of mir-499-5p and mir-499-3p and in the seed sequence of mir-499-3p. Therefore, it could have a double effect. On the one hand, a SNP located in a pre-miRNA region has the potential to impact the processing of pre-miRNAs into mature miRNAs (14) . Correspondingly, different genotypes of rs3746444 in pre-mir-499 have been associated with dysregulated expression of mir-499-5p in a colorectal cancer model (5) . These data are of particular interest considering that mir-499-5p seems to be upregulated in ALL (6) . On the other hand, SNP rs3746444 is also present in the seed region of a mature miRNA-499-3p and could be essential for the accurate recognition of target mRNA sequences. Potential targets of mir-499-3p (11) include FOXO1A (a transcription factor that is dysregulated in B-ALL (27)), MS4A1 or CD20 (a B-lymphocyte surface molecule that plays a role in the development and differentiation of B cells into plasma cells), and PBX1 (pre-B-cell leukemia homeobox 1 that is a dysregulated 
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Articles transcription factor in ALL) (28) . Therefore, alterations in the sequence of mir-499-5p and mir-499-3p, which affect expression of these miRNAs and/or the binding of mir-499-3p to target mRNAs, may have functional consequences for ALL. Among the SNPs located in pre-miRNA genes, other interesting result was that the rs10061133 G allele in mir-449b was associated with a decreased risk of ALL (P = 0.012). To our knowledge, this is the first time that this polymorphism has been associated with cancer risk. Based on its location, this polymorphism is also present in the mature sequence of the miRNA; therefore, it could affect the strength of miRNAmRNA binding, as well as miRNA levels. This miRNA has also been found to be upregulated in endometrial cancer and bladder cancer (29, 30) .
However, in this larger population, we have not replicated the association previously found in a small pilot study between rs2910164 in mir-146a and ALL risk (8) .
When we analyzed 72 polymorphisms present in miRNA biogenesis pathway, 8 of these were found to be significantly associated with ALL risk. Polymorphism rs139919 in TNRC6B was the SNP most highly associated with ALL susceptibility among the miRNA-processing genes, with the CC genotype associated with an increase in ALL risk (P = 0.011). TNRC6B encodes an RNA interference machinery component, which contributes to the RNA-induced silencing complex, and is crucial for miRNA-dependent translational repression or degradation of target mRNAs (31) . Although this SNP has not been analyzed previously, other genetic variants in TNRC6B have been associated with prostate cancer risk (31, 32) . It has also been suggested that alterations in the expression of TNRC6B are due to genetic variations that may affect mRNA levels that are normally regulated by TNRC6B, thereby affecting carcinogenesis (32) .
We have also found other SNPs located in genes which produce proteins that contribute to the RNA-induced silencing complex associated with ALL susceptibility. These included two SNPs in EIF2C1 (rs595961 and rs636832), one SNP in CNOT1 (rs11866002), and one SNP in CNOT6 (rs6877400). The SNPs rs595961 and rs636832 in EIF2C1 have been previously shown to be associated with renal cell carcinoma risk in males (33) and lung cancer (34), respectively. However, to our knowledge, this is the first study to identify an association between the SNPs, rs11866002 in CNOT 1 and rs6877400 in CNOT6, and cancer risk. In addition, it is hypothesized that rs595961, rs11866002, and rs6877400 have putative roles in transcription and/or regulation of splicing events, thereby affecting gene expression. SNPs that affect expression levels of these proteins may have deleterious effects on miRNA-mRNA interactions and may affect cancer development and progression. Correspondingly, EIF2C1 is frequently lost in human cancers such as Wilms tumor, neuroblastoma, and carcinomas of the breast, liver, and colon (35) .
Among the genes of biogenesis machinery, when we studied genes that contribute to the processing of pri-miRNAs to pre-miRNAs, we identified an association between SNPs and ALL risk. These SNPs included rs10035440 in DROSHA, and rs9606248 and rs1640299 in DGCR8. Interestingly, these three SNPs have putative roles in transcriptional regulation and may affect the expression levels of DROSHA or DGCR8. As a result, levels of miRNAs could be affected, leading to an increased ALL risk. Consistent with this hypothesis, a differentially expressed miRNA profile and DROSHA gene expression have been observed in relation to another SNP, rs640831, being present in the lung tissue (36) . Furthermore, increased expression of DROSHA and DGCR8 has been shown to dysregulate miRNAs present in the pleomorphic adenomas of the salivary gland (37) . In contrast, decreased expression of DROSHA and DGCR8 have been shown to accelerate cellular transformation and tumorigenesis (38) . Surprisingly, the association of these polymorphisms with the risk to develop other tumors has previously been analyzed (25, 33, 39) , and no significant association was found. However, they had not been analyzed in ALL patients until now.
In conclusion, the results of this study indicate that SNP rs12803915 located in pre-mir-612 and SNP rs3746444 located in pre-mir-499 may represent novel markers of B-ALL susceptibility. It would be of great interest to confirm these results in different cohorts of patients. To our knowledge, this is the first extensive study to report miRNA-related SNPs associated with ALL risk. 
METHODS
Study Participants
Genotyping
Genomic DNA was extracted from remission (containing less than 5% blast cells) peripheral blood, bone marrow slides or granulocytes isolated with Ficoll-Plaque PLUS (GE Healthcare Life Sciences, Piscataway, NJ), using the phenol-chloroform method (40) or from saliva samples using Oragene DNA kit (DNA Genotek, Ottawa, Canada) according to the manufacturer's instructions.
SNP genotyping was performed using TaqMan OpenArray Genotyping technology (Applied Biosystems, Carlsbad, CA) according to the published Applied Biosystems protocol. Initially, 131 SNPs were considered for analysis. After considering compatibility with the Taqman OpenArray platform, 118 SNPs were included in a Taqman OpenArray Plate (Applied Biosystems), and these included 72 SNPs present in 21 genes involved in miRNA biogenesis and 46 SNPs present in 42 pre-miRNA genes (see Supplementary Tables S4 and S5  online) .
Data were analyzed using Taqman Genotyper software (Applied Biosystems) for genotype clustering and genotype calling. Duplicate samples were genotyped across the plates.
Statistical Analyses
Statistical analyses were performed using R software (version v2.14.1; Institute for Statistics and Mathematics, Wien, Austria). To identify any deviation in Hardy-Weinberg equilibrium for the healthy controls (n = 387), a χ 2 test was used. The association between genetic polymorphisms in B-ALL patients and controls was also evaluated using the χ 2 or Fisher's exact test. Fisher's exact test was used if a genotype class had less than five individuals. We also tested the association considering genetic characteristics (hyperdiploid subtype and chromosomal translocations). The effect sizes of the associations were estimated by the odds ratio from univariate logistic regression and multivariate logistic regression to account for the possible confounding effect of sex.
The most significant test among codominant (major allele homozygotes vs. heterozygotes and major allele homozygotes vs. minor allele homozygotes), dominant (major allele homozygotes vs. heterozygotes + minor allele homozygotes), recessive (major allele homozygotes + heterozygotes vs. minor allele homozygotes), and additive (dosesdependent effect: major allele homozygotes vs. heterozygotes vs. minor allele homozygotes) genetic models was selected. In all cases, the significance level was set at 5%. The results were adjusted for multiple comparisons using the Bonferroni correction. 
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